Edwards Lifesciences
1,187 hedge funds and large institutions have $31.8B invested in Edwards Lifesciences in 2024 Q3 according to their latest regulatory filings, with 140 funds opening new positions, 369 increasing their positions, 495 reducing their positions, and 227 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
30% less capital invested
Capital invested by funds: $45.4B → $31.8B (-$13.5B)
38% less first-time investments, than exits
New positions opened: 140 | Existing positions closed: 227
60% less funds holding in top 10
Funds holding in top 10: 15 → 6 (-9)
Holders
1,187
Holding in Top 10
6
Calls
$733M
Puts
$296M
Top Buyers
| 1 | +$964M | |
| 2 | +$595M | |
| 3 | +$455M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$241M |
| 5 |
BlackRock
New York
|
+$238M |
Top Sellers
| 1 | -$881M | |
| 2 | -$592M | |
| 3 | -$487M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$381M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$275M |